Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-07 · 43 (7) · 1111-1123
DOI: 10.1161/atvbaha.122.318892 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-07. Verfasst von Enrico Maiorino und 1 weiteren Autor:innen. Beteiligte Einrichtung: Channing Division of Network Medicine (E.M., J.L.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Multiomics, Phenomics. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS, American Heart Association-American Stroke Association.
Abstract (Originalsprache)
The complex landscape of cardiovascular diseases encompasses a wide range of related pathologies arising from diverse molecular mechanisms and exhibiting heterogeneous phenotypes. This variety of manifestations poses significant challenges in the development of treatment strategies. The increasing availability of precise phenotypic and multiomics data of cardiovascular disease patient populations has spurred the development of a variety of computational disease subtyping techniques to identify distinct subgroups with unique underlying pathogeneses. In this review, we outline the essential components of computational approaches to select, integrate, and cluster omics and clinical data in the context of cardiovascular disease research. We delve into the challenges faced during different stages of the analysis, including feature selection and extraction, data integration, and clustering algorithms. Next, we highlight representative applications of subtyping pipelines in heart failure and coronary artery disease. Finally, we discuss the current challenges and future directions in the development of robust subtyping approaches that can be implemented in clinical workflows, ultimately contributing to the ongoing evolution of precision medicine in health care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Channing Division of Network Medicine (E.M., J.L.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- Division of Cardiovascular Medicine, Department of Medicine (J.L.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
ORCID-Profile: Enrico Maiorino, Joseph Loscalzo
Förderung
- NHLBI NIH HHS
- NHGRI NIH HHS
- American Heart Association-American Stroke Association
Zitieren
APA
Maiorino, E., & Loscalzo, J. (2023). Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(7), 1111-1123. https://doi.org/10.1161/atvbaha.122.318892
Vancouver
Maiorino E, Loscalzo J. Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(7):1111-1123. doi:10.1161/atvbaha.122.318892
BibTeX
@article{Maiorino2023,
author = {Maiorino, Enrico and Loscalzo, Joseph},
title = {Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
volume = {43},
number = {7},
pages = {1111--1123},
doi = {10.1161/atvbaha.122.318892}
}
EUVIMED